Europe Market Report for Bone Graft Substitutes 2017 – MedCore

Europe Market Report for Bone Graft Substitutes 2017 – MedCore


Bones are biologically active tissues that allow for movement, provide protection for the body’s other organs and serve as a production center for red and white blood cells. When bones are diseased or damaged, bone grafts and bone graft substitutes are used for bridging the resulting void or for providing the support that has been lost. The transplanted (or implanted) material provides a scaffold on which the body can generate new bone tissue, thereby repairing the skeletal system. The most common usage of such materials is for dental implants to replace missing teeth. Within the orthopedic field, however, spinal fusion surgeries are the largest driver of bone graft and bone graft substitute usage. Direct competition for bone graft substitutes comes from bone morphogenetic proteins which, although more expensive, are more effective at stimulating bone growth. Another source of competition is the rise of the motion preservation market for spinal surgery.

  • Year: 2017
  • Scope: 2013-2023
  • Region: Europe
  • Published Date: 6/1/2017
  • Pages: 612
  • Type: MedCore

General Report Contents
• Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
• Market Drivers & Limiters for each chapter segment
• Competitive Analysis for each chapter segment
• Section on recent mergers & acquisitions
As of 2016, the largest and fastest growing segment in the market was for synthetic bone graft substitutes. The strong growth of the synthetic market was a result of the affordability of synthetic products, as well as the strict regulations of allograft and DBM product usage throughout Europe. Furthermore, synthetic products have a very low risk of infection, which is another driver of growth.
Both the smallest and fastest declining segment was the DBM market. The decline in the DBM market was a result of high price and lack of clinical evidence regarding the product’s benefits. DBM products are commonly banned in the Scandinavian regions. While the majority of the 15 countries show a decline in DBM, both in price and quantity, consumption of DBM products in the U.K. and Switzerland are set to show moderate increases. This is due to the strong nation-wide beliefs in the products. Surgeons in these countries believe in the product and it is predicted that their demand will remain constant over the forecast period.
The second largest segment in 2016 was the allograft market. The larger ASP of allograft material allowed it to remain the market leader until recently. Allografts were particularly popular in the U.K. and Spain. While allograft material had been on the decline in Italy due to cultural disapproval, it is predicted that the Italian market will, over the forecast period, grow more accepting of using these materials.

The "Europe Market Report Suite for Orthopedic Biomaterials 2017 - MedSuite" includes analysis on the following companies currently active in this market:
TRB Chemedica
Meda Pharma
Sanofi Genzyme
Depuy Synthes
Laboratoire Genevrier
RTI Biologics
Zimmer Biomet
Others include: Anika Therapeutics, Bioiberica, Documedica, Ferring, Geistlich, Integra Biologics, Kuros, LCA Pharma, Orotech, Plasmaconcept AG, Stella PharmaceuticalsAlphatec Spine, etc
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Not Exactly What You Need?

Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers